CD8A and neoplasm: For example, when combined with 5-fluorouracil (5-FU) for colon cancer treatment, APS decreased tumor size by reducing indoleamine-2,3-dioxygenase (IDO1) expression in the TME and enhancing CD8+ T-lymphocyte infiltration [124].